The use of high-sensitivity assays for C-reactive protein in clinical practice. - Wikidata - wikimedia - TriplyDB

The use of high-sensitivity assays for C-reactive protein in clinical practice.

The use of high-sensitivity assays for C-reactive protein in clinical practice.

http://www.wikidata.org/entity/Q37090943

about

CRP in cardiovascular disease Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes.Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease.Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes.Changes in C-reactive protein during weight loss and the association with changes in anthropometric variables in men and women: LIFE Study.C-Reactive Protein: How Has JUPITER Impacted Clinical Practice?Modulatory Effect of Inflammation on Blood Pressure Reduction via Therapeutic Lifestyle Change.Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis.Association of High Sensitivity C-Reactive Protein Concentrations and Metabolic Syndrome among Thai Adults.Java project on periodontal diseases: effect of vitamin C/calcium threonate/citrus flavonoids supplementation on periodontal pathogens, CRP and HbA1c.The association between autonomic dysfunction, inflammation and atherosclerosis in men under investigation for carotid plaques High-Sensitivity C-Reactive Protein is Related to Central Obesity and the Number of Metabolic Syndrome Components in Jamaican Young Adults.Should C-reactive protein be a target of therapy?Impact of ezetimibe on atherosclerosis: is the jury still out?Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach Impact of aerobic exercise on levels of IL-4 and IL-10: results from two randomized intervention trials.The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).Plasma protein-bound di-tyrosines as biomarkers of oxidative stress in end stage renal disease patients on maintenance haemodialysis.Study of High Sensitive C-Reactive Protein (HS-CRP) After Cardiac Rehabilitation Program in Patients Undergoing Isolated CABG.Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis.Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.Clinical relevance for lowering C-reactive protein with statins.High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.Association between C-reactive protein and physical performance in older populations: results from the International Mobility in Aging Study (IMIAS).Routine serum C-reactive protein and stroke outcome after intravenous thrombolysis.Survival Advantage Mechanism: Inflammation as a Mediator of Positive Self-Perceptions of Aging on Longevity.Dietary intake and cardiometabolic biomarkers in relation to insulin resistance and hypertension in a middle-aged and elderly population in Beijing, China.Combined body mass index with high-sensitivity C-reactive protein as independent predictors for chronic kidney disease in a relatively healthy population in Taiwan.Oxidative stress and insulin resistance in policemen working shifts.

P2860

Q28268282-F5511A44-0FC3-4582-B388-4A8C97342821 Q33937311-C0DE2024-89FB-4019-9B05-44D94AA1790F Q34027430-1C34B0E5-EB18-4EC2-83E2-E2E65B5759EA Q34048554-0A91D24E-5458-444E-8308-793500477FDF Q34420387-FFDC6002-B2C9-4294-941F-8E38D9A85D53 Q34440730-D1E7CADD-5DD0-4479-B74A-9A6E6752E8AB Q34986430-F6790F8D-880D-4AA2-A75E-B213E4735150 Q34986455-BBA51386-A8D2-4D9D-AB7A-9652527C67C8 Q35088117-EB169FFA-2203-4B64-822A-3FF7381D0F79 Q35665122-E0AFF15D-F8CE-4C29-A594-324BC4AAC256 Q35835532-E9DBA7AA-ABCE-463C-A700-03C7960DFD8C Q36334087-AE26E67B-BB00-4A8A-8C79-4C05026FD79A Q36344725-701ED4AD-48FE-4A13-AEBE-839A237FE345 Q36783729-B0379C21-A069-4447-9698-430A41AF2D64 Q37151389-15000D9D-9DD2-4276-BCEA-6E02CDFE981A Q37197634-5587EF9D-B660-488C-A2F0-8D2B0FFDA903 Q37285574-4EDA04B7-A9E8-4F64-BDC1-9D5D110992DD Q37321111-8EF6A744-4DFF-46F1-973A-3949049ED553 Q37505886-0F1797CA-F056-4EFD-A35A-6B8D2F5E4E1F Q37600685-3B159C7A-8369-498E-8371-EA5FEF7A7B74 Q37608077-A8C85056-E183-483F-ABD4-D0C61D64D63B Q37609683-36BE0C33-1FD0-4B51-B7CC-F4473A0C1434 Q37825592-C6C4B41A-087A-4EA0-AAE1-F36AE2E4401E Q38880500-43EEA243-F448-453C-8786-36527E828B51 Q38913955-871E95D9-E7B8-4D98-9249-800511829486 Q39354235-1DF0743C-5E82-4A32-9057-AB0C456DDF57 Q40046981-153A6BEC-C209-4991-99C1-D232DD889ED5 Q44792514-A90F51BE-582B-49DB-9CD0-75B09F240040 Q50221747-07231377-A872-4522-9432-927A74714C44 Q51267744-146BA4C4-81A7-43D5-94DA-A8AD828EDA34 Q53793103-861C998B-4CB8-4DF7-A6D0-1725E7EF6435 Q53829403-B8F9FA00-C820-434F-9A81-8DB584AD9B4A

P2860

The use of high-sensitivity assays for C-reactive protein in clinical practice.

http://www.wikidata.org/entity/Q37090943

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The use of high-sensitivity assays for C-reactive protein in clinical practice.

@en

The use of high-sensitivity assays for C-reactive protein in clinical practice.

@nl

type

label

The use of high-sensitivity assays for C-reactive protein in clinical practice.

@en

The use of high-sensitivity assays for C-reactive protein in clinical practice.

@nl

prefLabel

The use of high-sensitivity assays for C-reactive protein in clinical practice.

@en

The use of high-sensitivity assays for C-reactive protein in clinical practice.

@nl

P1433

Q37090943-312DA9B1-E961-4DB9-AC42-D37821609D0C

P1476

Q37090943-F8874D64-1A80-42AC-A88C-75100000DB30

P2093

Q37090943-159006B2-FAFE-413A-8014-B88660BCDF54

Q37090943-5FDEBA31-9F22-4C09-946A-89150389E590

Q37090943-7D7E971E-D95C-4DCA-A06F-8D82D9950990

Q37090943-A57F31D7-B198-4AEB-A035-EC9AFEBD861A

Q37090943-C83D90E9-07CC-41C8-8876-3DB6C2BD30EC

Q37090943-D72D933F-34FF-464A-AE6B-183ABCC8835A

Q37090943-DC238B13-9714-4CD8-9740-A9C92775C943

Q37090943-E2ECEFC4-89C8-4893-B787-D0015D73C5EF

Q37090943-F534F05E-A0E2-4D7B-9938-2F3E31530F05

Q37090943-F7A6E370-D5E6-4C7F-B877-ACB5FA3E26A1

P2860

Q37090943-067C88FA-3A49-442E-94CD-54B7B69650FB

Q37090943-08A3D07B-3613-4F5A-8E50-077CF81138E2

Q37090943-0AA2A1BD-88CD-4F8C-A150-507506C8B4E2

Q37090943-0BABBA89-8254-4726-9702-76BB71091929

Q37090943-0E104857-1890-4F83-8E94-B6A270525411

Q37090943-12198192-507F-4B65-AB04-78D51D65B026

Q37090943-14B2540C-6849-45E3-8984-1E5C1DCFA65D

Q37090943-15A0C8F9-5E88-4EF6-927C-8753E5132745

Q37090943-1981EB2C-BA6D-4611-B343-919180DAB223

Q37090943-1A1EA94C-446F-4A6C-A606-6AE96EF9253E

P304

Q37090943-A535BAD1-BA1D-416A-8A3B-D0F76E13E220

P31

Q37090943-00b63ed7-4d7f-486d-b540-87773d861ccf

Q37090943-8A8BF20C-E0C7-4754-809D-8E7E01EC9A4F

P356

Q37090943-2D10FB5E-C476-4989-9803-7995DA13380D

P433

Q37090943-38775AF0-651E-4430-AAF3-FB459F4337E6

P478

Q37090943-1C930683-2C2F-4EFB-A4FA-289943896DE4

P50

Q37090943-7380D0BC-95A0-4287-A42E-A41DC6D4E9AA

Q37090943-D82471D3-4E8E-4978-BD28-C5A930465EAA

P577

Q37090943-04B81E1A-0B06-46E2-8216-159BBA0C1EE3

P5875

Q37090943-DE134289-9ACF-43A6-BCCA-0EA563835421

P698

Q37090943-E57AA2A3-1346-4F27-B75E-1EB158819B52

P932

Q37090943-3D3629D4-6F81-4359-9B3A-681492B9193F

P356

P1433

Nature Clinical Practice Cardiovascular Medicine

P1476

The use of high-sensitivity assays for C-reactive protein in clinical practice.

@en

P2093

Brian G Kral

http://www.w3.org/2001/XMLSchema#string

Catherine Y Campbell

http://www.w3.org/2001/XMLSchema#string

James T Willerson

http://www.w3.org/2001/XMLSchema#string

Kiran Musunuru

http://www.w3.org/2001/XMLSchema#string

Michael H Davidson

http://www.w3.org/2001/XMLSchema#string

Milind Y Desai

http://www.w3.org/2001/XMLSchema#string

Richard A Lange

http://www.w3.org/2001/XMLSchema#string

Roger S Blumenthal

http://www.w3.org/2001/XMLSchema#string

Samia Mora

http://www.w3.org/2001/XMLSchema#string

Ty J Gluckman

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Atherosclerosis — An Inflammatory Disease

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Inflammation, atherosclerosis, and coronary artery disease

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

P304

621-635

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPCARDIO1322

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Valentín Fuster Carulla

P577

2008-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23178720

http://www.w3.org/2001/XMLSchema#string

P698

18711404

http://www.w3.org/2001/XMLSchema#string

P932

2639398

http://www.w3.org/2001/XMLSchema#string